Denosumab--a novel strategy to prevent structural joint damage in patients with RA?
Standard
Denosumab--a novel strategy to prevent structural joint damage in patients with RA? / Schett, Georg; David, Jean-Pierre.
In: Nature clinical practice. Rheumatology, Vol. 4, No. 12, 01.12.2008, p. 634-5.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research
Harvard
Schett, G & David, J-P 2008, 'Denosumab--a novel strategy to prevent structural joint damage in patients with RA?', Nature clinical practice. Rheumatology, vol. 4, no. 12, pp. 634-5. https://doi.org/10.1038/ncprheum0927
APA
Schett, G., & David, J-P. (2008). Denosumab--a novel strategy to prevent structural joint damage in patients with RA? Nature clinical practice. Rheumatology, 4(12), 634-5. https://doi.org/10.1038/ncprheum0927
Vancouver
Schett G, David J-P. Denosumab--a novel strategy to prevent structural joint damage in patients with RA? Nature clinical practice. Rheumatology. 2008 Dec 1;4(12):634-5. https://doi.org/10.1038/ncprheum0927
Bibtex
@article{7cfbfaee2184478082978900d8cbe3d6,
title = "Denosumab--a novel strategy to prevent structural joint damage in patients with RA?",
author = "Georg Schett and Jean-Pierre David",
year = "2008",
month = dec,
day = "1",
doi = "10.1038/ncprheum0927",
language = "English",
volume = "4",
pages = "634--5",
number = "12",
}
RIS
TY - JOUR
T1 - Denosumab--a novel strategy to prevent structural joint damage in patients with RA?
AU - Schett, Georg
AU - David, Jean-Pierre
PY - 2008/12/1
Y1 - 2008/12/1
U2 - 10.1038/ncprheum0927
DO - 10.1038/ncprheum0927
M3 - SCORING: Journal article
C2 - 18839011
VL - 4
SP - 634
EP - 635
IS - 12
ER -
